In the past decade, great strides have been made in the prevention, detection, and treatment of HIV/AIDS. Despite these advances, significant political, economic, social, and scientific hurdles remain. In the more than two decades since the beginning of the HIV/AIDS epidemic, over 60 million people worldwide have become infected with HIV, including more than 20 million who have already died. Women now comprise almost half of adults living with HIV/AIDS with young people disproportionately bear the brunt of the epidemic. Only a fraction of those in need of have access to antiretroviral therapy or are reached by prevention programs and funding for HIV/AIDS from governments and other donors falls far short of projected need.
In the United States, almost one million people are estimated to be living with HIV/AIDS, and about 40,000 new HIV infections are detected annually. Minority communities, young people, women, and men who have sex with men have been particularly hard hit. Many of the programs such as Medicaid, ADAP and Ryan White funds, that provide care, treatment, support, and prevention to people at risk for and living with HIV in the U.S. face considerable resource constraints. In the U.S. and abroad, HIV/AIDS epidemic places unique challenges on healthcare delivery and financing, clinical research, and the public health infrastructure.
This section's materials address research, analysis, and the latest data and statistics on HIV/AIDS policy.